Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Waverley Pharma Inc V.WAVE

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. The Company is focused on the generic oncology injectable market in Europe, the United Kingdom (UK), and North America. The Company, through its subsidiaries, has entered into a license, manufacture, supply, marketing and distribution... see more

Bullboard (TSXV:WAVE)

View:
Post by Investingshaton Aug 19, 2020 2:18pm

Buy rvv thank me later

There was a halt today news is coming it's already up  Asian and Canada health approval 
Comment by moneywinner1on Aug 19, 2020 9:59am

RE:RE:More Drug Approvals & Product Deals before year end

Buy cheap what is going to have huge run 
Comment by tankingfrankon Aug 17, 2020 11:09am

RE:RE:News this week for sure

i am more concerned with MMCAP selling. 
Comment by Investor62on Aug 17, 2020 10:29am

RE:News this week for sure

what kind of News are you expecting?
Comment by lotsofideason Aug 15, 2020 11:03am

RE:More Drug Approvals & Product Deals before year end

have you askedthe ceo about the other company he is ceo of: Medicure, mph? Stock trades at about value of its cash in the bank.@
Comment by north40on Aug 15, 2020 2:06am

RE:RE:More Drug Approvals & Product Deals before year end

I think i know! Vxl ? Ubx? Myco?Let sona alone companies need to surface as winners on their own
Comment by north40on Aug 15, 2020 2:01am

RE:More Drug Approvals & Product Deals before year end

Again with the Sona! I own sona at .86 cents, All over it says like sona on many boards How can so many be like saina, Rvv thrm say nxo agn qsc hrh and many more are all reported to be -Like Sona! Are ...more  
Comment by bullmarketson Aug 14, 2020 1:49pm

RE:Waiting is killing it

There is a chance there will be news next week. Fair bit of volume the last couple of days. Not going to take much. 
Comment by tankingfrankon Aug 14, 2020 11:27am

RE:RE:Sold all my shares

i have no idea when - but this stock will be 50 cents plus in 2020 
Comment by pinkfloyd90on Aug 14, 2020 9:15am

RE:Sold all my shares

once a fool...always a fool....low float...one nr and this goes up 50% to 200% .all in all...your just another brick in the wall....Pink Floyd 1979.80 The Wall
Post by SleepingDWMeUpon Aug 13, 2020 8:57pm

Sold all my shares

Good lucky next week
Comment by AGResearchon Aug 13, 2020 5:27pm

RE:Bullish Momentum Shift

Take a look at something like THRM for comparison — another company working on saliva based COVID-19 test. It has triple the mkt cap, more than triple the float, tons of cheap paper as low as .05 ...more  
Post by MidtownGuyon Aug 13, 2020 3:49pm

Waiting is killing it

This stock bleeds off 5-10% a day now on no news. Tough to watch.
Post by AGResearchon Aug 13, 2020 1:49pm

Bullish Momentum Shift

Technical chart is signalling a bullish momentum shift with EMA 20 crossing over EMA 50. Today's push down failed with strong support coming in at .175. If recent action was the result of short ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities